A new generation of artificial intelligence (AI) tools designed to allow rapid, low-cost detection of clinically actionable genomic alterations directly from tumor biopsy slides has been developed by a team led by engineers and medical researchers at University of California San Diego.
Opinion | Seek and Ye Shall Find Afib in Stroke Survivors
Rose is a vascular neurologist. In 2023, stroke remains the fifth leading cause of death in the U.S. and a leading cause of long-term disability.
November 9, 2023